Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Gerlinger

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
BMC Medicine|November 16, 2016
Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinomaShanthini M Crusz, Yen Zhi Tang, Shah-Jalal Sarker, et al.
Nature Ecology & Evolution|May 21, 2021
Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancerAndrew Woolston, Louise J Barber, Beatrice Griffiths, et al.
European Radiology|July 16, 2020
Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding riskNicos Fotiadis, Katja N De Paepe, Lawrence Bonne, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2022
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistanceLucien Torlot, Anna Jarzab, Johanna Albert, et al.
BJS Open|February 23, 2022
Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched studyOsama Moussa, Ricky Harminder Bhogal, George Malietzis, et al.
Cell Genomics|May 20, 2025
Phenotypic heterogeneity and plasticity in colorectal cancer metastasisSamuel Ogden, Nasrine Metic, Ozen Leylek, et al.
Clinical Colorectal Cancer|November 14, 2017
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control StudyHamzeh Kayhanian, Emily Goode, Francesco Sclafani, et al.
European Urology|July 23, 2014
Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkersSakshi Gulati, Pierre Martinez, Tejal Joshi, et al.
Nature Communications|January 18, 2020
Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancerKatharina von Loga, Andrew Woolston, Marco Punta, et al.
Nature Communications|January 31, 2020
Author Correction: Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancerKatharina von Loga, Andrew Woolston, Marco Punta, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
BMC Medicine|November 16, 2016
Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinomaShanthini M Crusz, Yen Zhi Tang, Shah-Jalal Sarker, et al.
Nature Ecology & Evolution|May 21, 2021
Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancerAndrew Woolston, Louise J Barber, Beatrice Griffiths, et al.
European Radiology|July 16, 2020
Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding riskNicos Fotiadis, Katja N De Paepe, Lawrence Bonne, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2022
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistanceLucien Torlot, Anna Jarzab, Johanna Albert, et al.
BJS Open|February 23, 2022
Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched studyOsama Moussa, Ricky Harminder Bhogal, George Malietzis, et al.
Cell Genomics|May 20, 2025
Phenotypic heterogeneity and plasticity in colorectal cancer metastasisSamuel Ogden, Nasrine Metic, Ozen Leylek, et al.
Clinical Colorectal Cancer|November 14, 2017
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control StudyHamzeh Kayhanian, Emily Goode, Francesco Sclafani, et al.
European Urology|July 23, 2014
Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkersSakshi Gulati, Pierre Martinez, Tejal Joshi, et al.
Nature Communications|January 18, 2020
Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancerKatharina von Loga, Andrew Woolston, Marco Punta, et al.
Nature Communications|January 31, 2020
Author Correction: Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancerKatharina von Loga, Andrew Woolston, Marco Punta, et al.
Pageof 7